This contract expires in 165 days (Sep 29, 2026).
THE CORPORATION OF MERCER UNIVERSITY - IN VITRO TESTS TO SUPPORT BIOEQUIVALENCE DETERMINATION WHEN GENERIC DERMATOLOGICAL FORMULATION HAS DIFFERENCES FROM THE BRAND PRODUCT FORMULATION
Key Details
Description
IN VITRO TESTS TO SUPPORT BIOEQUIVALENCE DETERMINATION WHEN GENERIC DERMATOLOGICAL FORMULATION HAS DIFFERENCES FROM THE BRAND PRODUCT FORMULATION
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.